language_icon
EN
HI

EVOQ Remedies Share price

EVOQ

3.11

0.10 (-3.12%)
Last updated on 3 Jun, 2026 | 14:46 IST
Today's High

3.21

Today's Low

3.11

52 Week Low

2.27

52 Week High

6.11

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

EVOQ Remedies Chart

EVOQ Remedies Share Key Metrics

Volume
20000.00
Market Cap
7.99 CR
LTQ@LTP
8000@3.11
ATP
3.13
Var Margin
53.5 %
Circuit Range
2.57-3.85
Delivery %
100 %
Value
62600.00
ASM/GSM
No
Market Lot
4000

Summary

EVOQ Remedies share price is ₹3.11 as of 4 Jun, 2026. The stock EVOQ Remedies intraday movement has stayed between ₹3.11 and ₹3.21, while on a 52-week basis,EVOQ Remedies price 52 week high is ₹6.11 & its 52 week low is ₹2.27.
In terms of trading activity, EVOQ Remedies has recorded a volume of 20000 shares, The EVOQ Remedies has a market cap of ₹24900000 CR. The stock’s Average Traded Price (ATP) stands at ₹3.13, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 8000 @ ₹3.11.
EVOQ Remedies operates within a circuit range of ₹2.57 – ₹3.85, with a Value of ₹62600.00. The Delivery Percentage for the day is 100%. Additionally, EVOQ Remedies currently falls under the No framework, and trades with a market lot size of 4000.

EVOQ Remedies Fundamentals

View More
P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

40.06

Sector P/B

2.24

Sec. Div. Yield

78.08

EVOQ Remedies Resistance and Support

Pivot 3.22

Resistance

First Resistance

3.23

Second Resistance

3.25

Third Resistance

3.26

Support

First Support

3.2

Second Support

3.19

Third Support

3.17

EVOQ Remedies Shareholding Pattern

View More
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

0.02%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0%

Retail

99.98%

Others

0%

Total Promoters
MAR '26
0.02%

EVOQ Remedies Corporate Actions

DateAgenda
2026-05-30Half Yearly Results
2026-05-27Half Yearly Results
2026-05-14Audited Results
2025-10-10Quarterly Results
2025-10-09Half Yearly Results
2025-05-06Preferential issue of shares
2025-04-29Others
2025-04-25Preferential issue of shares & Others
2025-04-18Preferential issue of shares & Others
2025-04-10Audited Results

EVOQ Remedies News

Evoq Remedies Ltd - 543500 - Integrated Filing (Finance) For The Half Year And Year Ended On 31St March, 2026

Evoq Remedies received a qualified audit opinion with material uncertainty regarding its ability to continue as a going concern for FY26. The auditor noted non-compliance with related party transactions, unconfirmed debtor balances, significant tax demands, an ongoing SEBI investigation, and severely curtailed operations.
May 30 2026 19:44:22

Evoq Remedies Ltd - 543500 - Appointment Of M/S. Jay Pandya & Associates (FRN: S2024GJ963300), Company Secretaries, Ahmedabad, As Secretarial Auditor Of The Company For The Financial Year 2025-26.

Evoq Remedies' auditor issued a qualified opinion with material uncertainty about the company's ability to continue as a going concern. Key issues include non-compliant related party loans, unconfirmed debtor/supplier balances, unpaid statutory dues (income tax, TDS, GST demand), lack of internal auditor, cash losses, and an active SEBI investigation concerning financial statements and preferential issue proceeds.
May 30 2026 19:42:17

Evoq Remedies Ltd - 543500 - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Saturday, 30Th May, 2026 And Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015

Evoq Remedies reported H1 FY26 net loss of ₹29.42 lakhs. The auditor issued a qualified opinion due to material uncertainty about going concern, related party loan non-compliance, unconfirmed debtor balances, and an ongoing SEBI investigation.
May 30 2026 19:33:26

Evoq Remedies Ltd - 543500 - Board Meeting Intimation for Intimation For Rescheduling Of Board Meeting From 27Th May, 2026 To 30Th May, 2026

Evoq Remedies Board meeting, originally scheduled for May 27, 2026, has been rescheduled to May 30, 2026. The board will consider audited financial results for the half year and full year ended March 31, 2026, along with the Auditor's Report.
May 27 2026 12:42:42

Evoq Remedies Ltd - 543500 - Board Meeting Intimation for Intimation For Rescheduling Of Board Meeting From 14Th May, 2026 To 27Th May, 2026

Evoq Remedies rescheduled its Board Meeting from May 14 to May 27, 2026. The meeting will consider the audited financial results for the half year and year ended March 31, 2026, along with the Auditor's Report.
May 11 2026 18:17:21

Evoq Remedies Ltd - 543500 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday, 14Th May, 2026

Evoq Remedies' Board of Directors will meet on May 14, 2026, to consider and approve the audited financial results for the Half Year and Year ended March 31, 2026. The meeting will also review the Auditor's Report.
May 07 2026 17:12:28
Read More

EVOQ Remedies Management

NamePosition
Bhumishth PatelManaging Director
Narendrakumar PatelNon Executive Director
View More

EVOQ Remedies FAQs

The Buying Price of EVOQ Remedies share is 3.11 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy EVOQ Remedies stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for EVOQ Remedies, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of EVOQ Remedies shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio EVOQ Remedies shares is 0. Useful to assess the stock's value relative to its book value.

To assess EVOQ Remedies’s valuation compare Sector P/E, P/B which are 40.06 & 2.24 with sector averages, along with growth rates and financial metrics.

The Market Cap of EVOQ Remedies is 7.99 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of EVOQ Remedies share price is 6.11 & 2.27. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

EVOQ Remedies belongs to the Miscellaneous sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost